FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 心动有限公司 呈交日期： 2025年7月23日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 02400 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | 已發行股份（不包括庫存股份 ...

Group 1 - The report highlights two main investment themes for 2025: 1) Accelerated AI application deployment and the continuous expansion of Agent capabilities, impacting industries such as marketing, e-commerce, education, film, and gaming, while also focusing on opportunities in AI toys and hardware [4][12] - The IP derivative products sector is entering a high-speed development phase, with spiritual and self-consumption becoming long-term growth points for consumption. The report is optimistic about high-quality domestic IPs expanding online content and offline physical derivatives to enhance their influence and open up commercialization opportunities [4][12] Group 2 - In the AI sector, the report notes that the application capabilities of Agents are continuously expanding, with significant advancements in model performance and multi-modal capabilities. OpenAI's o3 model and Google's Veo3 are leading the way in this evolution, while domestic models are narrowing the gap with international leaders [10][17][19] - The report emphasizes the rise of spiritual consumption and the expansion of the IP derivative products market, with companies like Pop Mart and MiHoYo successfully leveraging their IPs for international expansion and revenue growth [11][54][60] Group 3 - The report identifies key companies to watch, including Pop Mart, Light Media, Giant Network, Kunlun Wanwei, and others, which are expected to benefit from the trends in AI applications and IP derivatives [12] - The report also discusses the increasing commercialization of AI applications, with companies like Kuaishou's Keling and Meitu seeing significant revenue growth driven by their AI capabilities [44][47] Group 4 - The report outlines the importance of IP as a new production factor, reshaping the consumer sector and enabling companies to expand their revenue streams through effective IP management and commercialization strategies [52][60] - The analysis indicates that the market for IP derivative products is expected to grow significantly, with projections for the Chinese pan-entertainment product market reaching 335.8 billion yuan by 2029 [54][59]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 心动有限公司 呈交日期： 2025年7月22日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02400 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | 事件 | | 已發行股份（不包括庫存股份）數 目 | 佔有關 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 心动有限公司 呈交日期： 2025年7月21日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02400 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | 事件 | | 已發行股份（不包括庫存股份）數 目 | 佔有關 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 心动有限公司 呈交日期： 2025年7月18日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02400 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | 事件 | | 已發行股份（不包括庫存股份）數 目 | 佔有關 ...

Core Viewpoint - The recent public fund reports reveal that high-performing funds have achieved impressive returns by focusing on sectors like innovative pharmaceuticals and new consumption, while also highlighting a trend towards thematic funds targeting niche markets [1][2][5]. Fund Performance and Holdings - High-performing funds have seen significant returns, with the Changcheng Pharmaceutical Industry Fund achieving a return rate of 102.52% this year, driven primarily by its focus on innovative pharmaceuticals [2]. - Many top-performing funds in the first half of the year are pharmaceutical-themed, including Zhongyin Hong Kong Stock Connect Pharmaceutical and Huashan Pharmaceutical Biotechnology [2][3]. - The top holdings of several funds have shifted towards technology and pharmaceuticals, with notable new additions like Zhongji Xuchuang and Xin Yisheng in the top ten holdings of the China Europe Digital Economy Mixed Fund [3]. Thematic Funds and Sector Focus - Some actively managed funds have undergone significant portfolio changes, with a complete overhaul of their top holdings to focus on emerging sectors like robotics and short dramas [4]. - The Tongtai Industry Upgrade Mixed Fund increased its stock position from 30% to 90% and shifted its focus to robotics, while the Tongtai Huile Mixed Fund transitioned to short drama and gaming stocks [4]. - Fund companies are launching numerous thematic products targeting specific high-growth sectors, such as controllable nuclear fusion and deep-sea technology, indicating a trend towards specialized investment strategies [5]. Market Outlook - Fund managers maintain a positive outlook for the equity market in the third quarter, with confidence in the performance of related sectors [6]. - The Changcheng Pharmaceutical Industry Fund manager anticipates growth in innovative pharmaceuticals driven by overseas licensing and domestic sales, while the Tongtai Industry Upgrade Fund manager expects significant opportunities in the robotics sector due to increased production and technological advancements [6].

Group 1 - Yuanxin Technology has achieved systematic breakthroughs in three major areas of medical insurance, successfully connecting in-hospital patient services, out-of-hospital patient management, and health protection, benefiting over one million patients [1] - The "Yuanquan Partner Intelligent Agent Cluster" developed by Yuanxin Pharmacy has established a comprehensive out-of-hospital intelligent patient management system, enhancing the management capacity of pharmacists from 200 patients to a more efficient model [1] - The system utilizes an automated follow-up mechanism that sends medication guidance, disease knowledge, and refill reminders, creating personalized patient profiles for targeted service delivery [1][2] Group 2 - Significant results have been observed in patient management projects, with the medication cycle for a first-line Her-2 positive drug extending from 7.6 months to 7.9 months, and a 7.6% increase in PD-1 drug refill rates [2] - The system has managed over one million special drug patients, with more than 9 million patient interactions, achieving a 100% coverage rate for standardized special drug service processes [2] - Yuanxin Medical has launched a full-process task-based interaction system that integrates 11 functions, allowing patients to describe their needs via mobile, thus creating a closed-loop service experience [2] Group 3 - The multi-agent platform architecture serves as the core engine for efficient service, with a central coordinator linking various modules in real-time, ensuring local data processing and rapid response times [3] - Yuanxin Technology is transforming health insurance services from a "single policy" model to a "lifetime health service" model, addressing common user pain points such as slow response times and complex claims processes [3] - The AI customer manager developed by Yuanxin Huibao has achieved a 95% problem resolution rate, significantly improving efficiency compared to traditional methods [3] Group 4 - The integration of medical, pharmaceutical, and insurance services by Yuanxin Huibao creates a closed loop of "health prevention - diagnostic support - cost protection," shifting the essence of insurance from post-event compensation to proactive management [4]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 心动有限公司 呈交日期： 2025年7月16日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02400 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | 已發行股份總數 | | 事件 | | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不 ...

Summary of Conference Call Notes Industry or Company Involved - The discussion primarily revolves around the gaming industry, specifically focusing on the dynamics between mobile games, PC games, and the platforms that support them, such as TapTap and Steam. Core Points and Arguments 1. **Revenue Dynamics in Gaming** The revenue from older games is increasing, but the overall payment capacity of players may be reaching its limit. The decline in new game releases could be affecting player motivation to spend. [1] 2. **Supply Chain and Game Development** The supply of new games is expected to decrease due to project adjustments by many game companies. The timeline for new game releases is being pushed back, which may impact the industry negatively. [2] 3. **Multi-Platform Development** There is a growing trend towards multi-platform game development, where games are designed to be playable on both mobile and PC. This shift is seen as timely due to improvements in mobile game quality. [2][3] 4. **Differences Between Platforms** The business models of platforms like Steam and Type are fundamentally different. Steam has a more closed ecosystem, while Type is seen as attractive for developers due to its ad revenue model. [4] 5. **User Acquisition and Retention** The user acquisition path for PC games differs significantly from mobile games. The transition from mobile to PC gaming is becoming more fluid, allowing for easier user retention across platforms. [5][6] 6. **Market Trends and Advertising** The advertising strategies for games are evolving, with a potential shift towards more direct advertising on platforms like Type. The effectiveness of advertising on different platforms is dynamic and requires constant adjustment. [7][8] 7. **Impact of Major Clients** The performance of major clients like Tencent and Wangyi is crucial for the overall market. A decrease in new game supply could lead to market contraction, affecting distribution channels. [9] 8. **Future Game Releases** The uncertainty surrounding future hit games poses a risk for the industry. The next major game that could dominate the market is unpredictable, which adds to the overall market volatility. [10] 9. **User Experience and Community Engagement** Continuous optimization of user experience, especially in community-driven platforms, is essential. There is a focus on improving features that users have requested. [11] 10. **Apple's Ecosystem Changes** Potential changes in Apple's ecosystem, such as the possibility of allowing third-party app stores, could significantly impact user growth and advertising strategies for platforms like TapTap. [12][13] 11. **Profitability and Market Expectations** The company aims for a profit margin of around 30%, which is considered normal in the advertising industry. However, market expectations may have been set too high, leading to stock price fluctuations. [15][16] 12. **Market Ceiling for TapTap** The market ceiling for TapTap remains stable, with estimates suggesting it will not exceed 100 million users due to demographic limits. [17] 13. **Revenue Growth Potential** There is potential for revenue growth if the company can enhance its mobile monetization strategies. [17] 14. **Shareholder Returns** The company has plans for shareholder returns, including dividends, but the consistency of this policy is still uncertain. [17] 15. **Game Development Uncertainty** The relationship between development investment and commercial success is not guaranteed, highlighting the inherent risks in game development. [18][19] 16. **User Overlap Between Platforms** There is significant overlap between mobile and PC gamers, indicating that user engagement strategies should consider cross-platform play. [19][20] 17. **Company Valuation and Market Sentiment** The company's valuation is influenced by market sentiment and transparency in communication with investors. [20] Other Important but Possibly Overlooked Content - The discussion touches on the cultural aspects of the company, indicating a relatively relaxed environment, which may impact employee performance and creativity. [21] - There are ongoing considerations regarding the competitive landscape and the need for innovative game development to maintain market relevance. [22]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 心动有限公司 呈交日期： 2025年7月15日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 02400 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | 已發行股份（不包括庫存股份 ...